Literature DB >> 804274

Reversal of severe fatty hepatic infiltration after intestinal bypass for morbid obesity by calorie-free amino acid infusion.

S L Heimburger, E Steiger, P Lo Gerfo, A G Biehl, M J Williams.   

Abstract

Hepatic fatty infiltration complicating jejunoileal bypass can be massive and may require restoration of gastrointestinal continuity. This fatty infiltration appears to be caused by protein depletion associated with adequate or high carbohydrate intake. The present study has shown that calorie-free amino acid alimentation can reverse these changes. In three of thirteen patients who underwent 12 inch to 6 inch jejunoileal bypass procedures, symptomatic hepatomegaly developed with near total replacement of hepatocytes by massive fatty infiltration. After undergoing liver scan, liver biopsy, and liver function tests, the patients were started on a peripheral infusion of 2L per day of a 4.25 per cent crystalline amino acid solution, allowing for fat mobilization while preserving body protein stores. All oral intake was withheld except for water. At the end of a fourteen to twenty-one day infusion period, serum albumin levels increased by 1 gm in all patients. Decreases in liver volume of 83, 45, and 40 per cent occurred. During the infusion period ketonuria was 4 plus in all patients indicating active lipolysis. Weight loss was impressive (17, 19, and 40 pounds). All patients showed marked symptomatic improvement, and postinfusion liver biopsy specimens showed a return to near normal architecture. Maintenance of normal liver size by a high-protein, low-carbohydrate diet was observed in a five to seven month follow-up period. In contrast to previous studies using standard hyperalimentation solutions, the use of calorie-free amino acid solutions reverses the hepatic fatty infiltration seen after intestinal bypass by mobilization of fat. This fat mobilization does not occur as readily in the presence of large amounts of glucose.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 804274     DOI: 10.1016/0002-9610(75)90229-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  11 in total

Review 1.  An epilogue to jejunoileal bypass.

Authors:  R M Baddeley
Journal:  World J Surg       Date:  1985-12       Impact factor: 3.352

Review 2.  Surgical management of morbid obesity.

Authors:  S N Joffe
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

3.  Effect of improved absorption on development of jejunoileal bypass-induced liver dysfunction in rats.

Authors:  J A Vanderhoof; M J Metz; D J Tuma; D L Antonson; M F Sorrell
Journal:  Dig Dis Sci       Date:  1980-08       Impact factor: 3.199

4.  Abnormal liver function during nutritional support in postoperative cancer patients.

Authors:  F D Skidmore; D E Tweedle; E N Gleave; E Gowland; D A Knass
Journal:  Ann R Coll Surg Engl       Date:  1979-05       Impact factor: 1.891

5.  Liver injury following jejunoileal bypass. Are there markers?

Authors:  S M Nasrallah; C E Wills; J T Galambos
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

6.  Tuberculosis after jejuno-ileal bypass for morbid obesity.

Authors:  N Werbin
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

7.  Optimizing results of gastric bypass.

Authors:  E E Mason; K J Printen; C E Hartford; W C Boyd
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

8.  Amino acid and peptide absorption in bypassed jejunum following jejunoileal bypass in rats.

Authors:  A B Garrido; H J Freeman; Y S Kim
Journal:  Dig Dis Sci       Date:  1981-02       Impact factor: 3.199

9.  BSP clearance as the most reliable criterion of hepatic dysfunction after jejunoileal bypass in the rat: arguments in favor of the existence of a pathogenetic mechanism involving a transient malnutrition state.

Authors:  J F Grenier; J Marescaux; C Stock; G Coumaros; P Sava; F Michel
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

10.  Role of defunctionalized bowel in jejunoileal bypass-induced liver disease in rats.

Authors:  J A Vanderhoof; D J Tuma; M F Sorrell
Journal:  Dig Dis Sci       Date:  1979-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.